Nisa Investment Advisors LLC Lowers Position in MetLife, Inc. $MET

Nisa Investment Advisors LLC lessened its position in MetLife, Inc. (NYSE:METFree Report) by 8.4% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 186,738 shares of the financial services provider’s stock after selling 17,114 shares during the quarter. Nisa Investment Advisors LLC’s holdings in MetLife were worth $15,017,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in MET. Brighton Jones LLC lifted its stake in shares of MetLife by 9.0% in the 4th quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider’s stock valued at $347,000 after purchasing an additional 351 shares during the period. GAMMA Investing LLC increased its position in MetLife by 10.7% during the 1st quarter. GAMMA Investing LLC now owns 10,162 shares of the financial services provider’s stock valued at $816,000 after buying an additional 984 shares in the last quarter. PDS Planning Inc increased its position in MetLife by 13.2% during the 1st quarter. PDS Planning Inc now owns 2,784 shares of the financial services provider’s stock valued at $224,000 after buying an additional 324 shares in the last quarter. Transcend Capital Advisors LLC increased its position in MetLife by 24.7% during the 1st quarter. Transcend Capital Advisors LLC now owns 3,205 shares of the financial services provider’s stock valued at $257,000 after buying an additional 635 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its position in MetLife by 20.7% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 60,785 shares of the financial services provider’s stock valued at $4,735,000 after buying an additional 10,414 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Piper Sandler lowered MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 price objective for the company. in a research report on Friday, September 19th. Cowen restated a “buy” rating on shares of MetLife in a research note on Friday, August 22nd. Weiss Ratings restated a “buy (b)” rating on shares of MetLife in a research note on Saturday. Keefe, Bruyette & Woods decreased their price target on MetLife from $94.00 to $92.00 and set an “outperform” rating for the company in a research note on Monday, August 11th. Finally, Wells Fargo & Company boosted their price target on MetLife from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, MetLife has a consensus rating of “Moderate Buy” and a consensus target price of $95.18.

Read Our Latest Analysis on MET

MetLife Stock Performance

Shares of MET opened at $78.71 on Monday. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a one year low of $65.21 and a one year high of $89.05. The firm has a market capitalization of $52.34 billion, a P/E ratio of 13.34, a PEG ratio of 0.71 and a beta of 0.86. The business has a fifty day moving average of $80.37 and a 200 day moving average of $78.40.

MetLife (NYSE:METGet Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing the consensus estimate of $2.32 by ($0.30). MetLife had a return on equity of 19.88% and a net margin of 5.83%.The firm had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $18.58 billion. During the same period in the previous year, the firm earned $2.28 EPS. The business’s revenue was down 2.7% on a year-over-year basis. As a group, sell-side analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 4th will be given a $0.5675 dividend. This represents a $2.27 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Tuesday, November 4th. MetLife’s payout ratio is presently 38.47%.

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.